6-CHLORO-1H-INDAZOLE-4-CARBOXYLIC ACID, 95%, 250mg

Ethyl 2-oxo-5,6,7,8-tetrahydro-2H-chromene-3-carboxylate, 95.0%, 250mg

(1R,5S)-6-ISOPROPYL-3-(4-NITROLPHENYL)-3,6-DIAZABICYCLO[3.1.1]HEPTANE, 97.0%, 250mg

[2-(3-Methoxyphenyl)ethyl]hydrazine dihydrochloride, 1g

TERT-BUTYL (4-OXO-4,5-DIHYDROTHIAZOL-2-YL)CARBAMATE, 95.0%, 1g

[4-(1-pyrrolidinylcarbonyl)benzyl]amine hydrochloride hydrate, 95.0%, 1g

5-(Trifluoromethyl)benzo[c][1,2]oxaborol-1(3H)-ol, 98%, 100mg

(3AR,6R,6AR)-6-(((TERT-BUTYLDIMETHYLSILYL)OXY)METHYL)-2,2-DIMETHYLDIHYDROFURO[3,4-D][1,3]DIOXOL-4(3AH)-ONE, 95.0%, 1g

Trimethyl(tridecafluorohexyl)silane>97.0%(GC)5g

(1-(Trifluoromethyl)cyclopropyl)methyl methanesulfonate, 5g

Ponceau solution 0.1% in 5% acetic acid, 1L

(1S,2R)-2-((benzyloxy)carbonyl)cyclohexane-1-carboxylic acid, 98%, 500mg

TRIS, 5 kg, plastic